Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Adjuvia Therapeutics closes $8 million in Seed financing to advance ATI-105, a novel mitochondrial disease therapy, into Phase 1 clinical trials.
Amount Raised
$8 Million
Round Type
Seed
San FranciscoBiotechnologyHealth CareMedicalTherapeuticsDescription
Adjuvia Therapeutics has successfully raised $8 million in a Series Seed financing round. The funds will be used to advance ATI-105, a novel therapy for mitochondrial diseases, into Phase 1 clinical trials. This financing marks an important step in the company's development of innovative treatments. The company aims to address unmet medical needs in this area.
Watching Adjuvia Therapeutics? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan